§ 33-24-151 — 33-24-148. Conditions for drug substitution

(a) Repealed By Laws 2001, Ch. 54, § 2.
(b) Except as limited by W.S. 33-24-149(b) or when the
practitioner has clearly indicated substitution is not
permitted, a pharmacist may substitute:
(i) A drug product with the same generic name in the
identical strength, quantity, dose and dosage form as the
prescribed drug, provided the substituted product or drug meets
all requirements specified in W.S. 33-24-147(a)(ii);
(ii) An interchangeable biological product.
(c) Repealed By Laws 2001, Ch. 54, § 2.
(d) Repealed By Laws 2001, Ch. 54, § 2.
(e) A pharmacist may not substitute a generically
equivalent drug unless it has been manufactured with the
following minimum manufacturing standards and practices by a
manufacturer who:
(i) Marks capsules and tablets with an identification
code or monogram;
(ii) Labels products with their expiration date;
(iii) Maintains reasonable resources for product
information;
(iv) Maintains recall capabilities for unsafe or
defective drugs.
(f) Repealed By Laws 2001, Ch. 54, § 2.
(g) When a practitioner orally communicates a prescription
and prohibits substitution of an interchangeable biological
product or generically equivalent drug, the pharmacist shall
make reasonable efforts to obtain a written prescription from
the practitioner with the phrase "brand medically necessary"
written on the face of the prescription in his own handwriting.